Gene · 9739
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determination of Histone Methyltransferase Structures in Complex with the Nucleosome by Cryogenic Electron Microscopy. | Methods Mol Biol | 2022 | 35733015 | PubTator, text mining | PubMed |
| Mechanisms that regulate the activities of TET proteins. | Cell Mol Life Sci | 2022 | 35705880 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Mechanisms during Osteogenic Differentiation in Human Dental Follicle Cells. | Int J Mol Sci | 2022 | 35682637 | PubTator, text mining | PubMed |
| Monoubiquitination in Homeostasis and Cancer. | Int J Mol Sci | 2022 | 35682605 | PubTator, text mining | PubMed |
| An in vitro model of neuronal ensembles. | Nat Commun | 2022 | 35680927 | PubTator, text mining | PubMed |
| Dynamic mRNA degradome analyses indicate a role of histone H3K4 trimethylation in association with meiosis-coupled mRNA decay in oocyte aging. | Nat Commun | 2022 | 35680896 | PubTator, text mining | PubMed |
| SETD2: from chromatin modifier to multipronged regulator of the genome and beyond. | Cell Mol Life Sci | 2022 | 35661267 | PubTator, text mining | PubMed |
| Epidemiological Evidence for an Immune Component of Parkinson's Disease. | J Parkinsons Dis | 2022 | 35661019 | PubTator, text mining | PubMed |
| The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes. | Cell Biosci | 2022 | 35659740 | PubTator, text mining | PubMed |
| Sleep and Late-Onset Alzheimer's Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects. | Front Genet | 2022 | 35656316 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression. | Contrast Media Mol Imaging | 2022 | 35655723 | PubTator, text mining | PubMed |
| Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis. | Int J Mol Sci | 2022 | 35628612 | PubTator, text mining | PubMed |
| Polymerase ζ Is Involved in Mitochondrial DNA Maintenance Processes in Concert with APE1 Activity. | Genes (Basel) | 2022 | 35627264 | PubTator, text mining | PubMed |
| The Genetic and Molecular Basis of Developmental Language Disorder: A Review. | Children (Basel) | 2022 | 35626763 | PubTator, text mining | PubMed |
| A Three-Genes Signature Predicting Colorectal Cancer Relapse Reveals LEMD1 Promoting CRC Cells Migration by RhoA/ROCK1 Signaling Pathway. | Front Oncol | 2022 | 35619906 | PubTator, text mining | PubMed |
| Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site. | ACS Chem Biol | 2022 | 35613319 | PubTator, text mining | PubMed |
Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells. | Bioengineered | 2022 | 35611845 | PubTator, text mining | PubMed |
| Differences in H3K4me3 and chromatin accessibility contribute to altered T-cell receptor signaling in neonatal naïve CD4 T cells. | Immunol Cell Biol | 2022 | 35608955 | PubTator, text mining | PubMed |
| Cross talk between acetylation and methylation regulators reveals histone modifier expression patterns posing prognostic and therapeutic implications on patients with colon cancer. | Clin Epigenetics | 2022 | 35606881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9739/papers?page=25